AIS Healthcare ™
Intro/Problem Statement:
Chronic Pain, Targeted Relief
Living with chronic pain or severe muscle stiffness (spasticity) can make everyday activities difficult. Sometimes, medicines like pills or injections don’t work well enough or cause side effects. For patients in this situation, a more precise treatment may be needed.
Targeted Drug Delivery (TDD), is a treatment that delivers medicine directly to the area around your spinal cord using a small, implanted pump. This approach allows the medicine to work more effectively with smaller doses, which can help reduce side effects. TDD provides steady, long-lasting relief and can be customized for each patient.
How It Works / Trial
Solution:
What Is TDD?
TDD is a pharmacologic neuromodulation therapy where drugs like opioids, baclofen, or ziconotide are delivered directly into the intrathecal space. This allows targeted modulation of spinal neurons, glia, and synapses—rebalancing excitatory and inhibitory pathways in chronic pain conditions.
- Opioids reduce excitatory neurotransmission in dorsal horn neurons.
- Baclofen enhances inhibitory tone, relieving spasticity and hyperactive circuits.
- Ziconotide blocks calcium channels, preventing excitatory neurotransmitter release.
- Admixtures allow clinicians to tailor therapy to each patient’s neurobiology.
By focusing on the spinal cord, TDD achieves relief that systemic medications cannot match.
Who Can Benefit
TDD is appropriate for patients with:
- Refractory chronic pain unresponsive to systemic medications
- Cancer-related pain requiring high-dose opioids
- Severe spasticity from multiple sclerosis, spinal cord injury, or cerebral palsy
- High-risk opioid patients needing targeted therapy to reduce systemic exposure
Benefits of TDD
- Precise analgesia: High local concentrations, minimal systemic side effects
- Reduced opioid reliance: Lower doses achieve effective relief
- Functional improvement: Enhanced mobility, sleep, and quality of life
- Customized therapy: Flexible drug combinations and concentrations
Sustained management: Continuous infusion ensures consistent relief
Patient Testimonial
Real-world experiences highlight improved pain control, functional gains, and reduced medication burden.
Conditions Treated
Nonmalignant chronic pain, cancer pain, spasticity, and complex neurologic disorders responsive to spinal modulation.
TDD Implant
Visualizing the procedure helps patients understand safety and long-term management.
TDD Journey
- Evaluation & Consultation: Detailed assessment and imaging for suitability
- Implantation: Outpatient pump placement with precise catheter positioning
- Titration & Optimization: Dosing adjusted in collaboration with AIS nurses
Ongoing Care: Regular refills, monitoring, and dose modifications to sustain therapy
Resources
Patient Brochure
Covers: therapy overview, device function, dosing process, lifestyle considerations, safety, and questions to ask clinicians.
Conclusion: Targeted Drug Delivery is a sophisticated, patient-centered form of pharmacologic neuromodulation. AIS Healthcare’s integrated approach—sterile compounding, expert nursing, and quality oversight—ensures safe, precise, and long-lasting pain management. For patients with refractory pain or spasticity, TDD offers real relief, functional improvement, and a pathway to a better quality of life.